Laboratory Corp. of America Holdings  

(Public, NYSE:LH)   Watch this stock  
Find more results for LH
100.42
+0.57 (0.57%)
Apr 24 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 99.84 - 100.98
52 week 87.01 - 108.00
Open 100.58
Vol / Avg. 822,544.00/1.28M
Mkt cap 8.54B
P/E 16.06
Div/yield     -
EPS 6.25
Shares 85.02M
Beta 0.58
Inst. own 105%
May 14, 2014
Laboratory Corporation of America Holdings Annual Shareholder Meeting - 9:00AM EDT - Add to calendar
Apr 28, 2014
Q1 2014 Laboratory Corporation of America Holdings Earnings Release - 9:30AM EDT - Add to calendar
Apr 28, 2014
Q1 2014 Laboratory Corporation of America Holdings Earnings Conference Call - 9:00AM EDT - Add to calendar
Mar 11, 2014
Laboratory Corporation of America Holdings at Barclays Healthcare Conference - Webcast
Feb 7, 2014
Q4 2013 Laboratory Corporation of America Holdings Earnings Release
Feb 7, 2014
Q4 2013 Laboratory Corporation of America Holdings Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 8.82% 9.91%
Operating margin 14.96% 17.06%
EBITD margin - 21.40%
Return on average assets 7.44% 8.36%
Return on average equity 20.04% 22.03%
Employees 34,000 -
CDP Score - -

Address

358 S MAIN ST
BURLINGTON, NC 27215
United States - Map
+1-336-5845171 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Laboratory Corporation of America Holdings is a clinical laboratory company in the United States. Through a national network of laboratories, the Company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. In addition, it has developed specialty and niche operations based on certain types of specialized testing capabilities and client requirements, such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, diagnostic genetics and clinical research trials. It processes tests on approximately 470,000 patient specimens daily and provides clinical laboratory testing services in all 50 states, the District of Columbia, Puerto Rico, Belgium, Japan, the United Kingdom, China, Singapore and three provinces in Canada.

Officers and directors

David P. King Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William B. Hayes Chief Financial Officer, Executive Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James T. Boyle Jr. Chief Operating Officer, Executive Vice President
Age: 56
Bio & Compensation  - Reuters
F Samuel Eberts III Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer
Age: 53
Bio & Compensation  - Reuters
Mark Elliott Brecher M.D. Senior Vice President, Chief Medical Officer
Age: 57
Bio & Compensation  - Reuters
Robert E. Mittelstaedt Jr. Lead Independent Director
Age: 69
Bio & Compensation  - Reuters
D. Gary Gilliland M.D., Ph.D. Director
Bio & Compensation  - Reuters
Garheng Kong M.D., Ph.D. Director
Bio & Compensation  - Reuters
Kerrii B. Anderson Independent Director
Age: 56
Bio & Compensation  - Reuters
Jean-Luc Belingard Independent Director
Age: 65
Bio & Compensation  - Reuters